Mangalam Drugs & Organics has informed that the meeting of the Board of Directors of the Company will be held May 16, 2016, to approve, consider and take on record the Audited Financial Results of the Company for the quarter and year ended March 31, 2016. Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all directors, officers and designated employees of the Company from May 06, 2016 and would open 48 hours after the announcement of financial results to the public.
The above information is a part of company’s filings submitted to BSE.
